UBS AM
QTTB icon

UBS AM’s Q32 Bio QTTB Stock Holding History

UBS AM’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,640
Closed -$199K – 2784
2022
Q1 		$199K Hold
3,640
– – ﹤0.01% 2683
2021
Q4 		$239K Sell
3,640
-331
-8% -$32.1K ﹤0.01% 2733
2021
Q3 		$563K Sell
3,971
-524
-12% -$66.8K ﹤0.01% 2458
2021
Q2 		$588K Buy
4,495
+2,523
+128% +$315K ﹤0.01% 2473
2021
Q1 		$334K Buy
1,972
+416
+27% +$87.6K ﹤0.01% 2474
2020
Q4 		$316K Buy
1,556
+673
+76% +$130K ﹤0.01% 2401
2020
Q3 		$170K Buy
883
+189
+27% +$42.4K ﹤0.01% 2421
2020
Q2 		$190K Buy
694
+88
+15% +$23.5K ﹤0.01% 2399
2020
Q1 		$169K Hold
606
– – ﹤0.01% 2325
2019
Q4 		$226K Buy
+606
New +$174K ﹤0.01% 2446

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM's QTTB Position: Q2 2022 in Review

UBS AM sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 3,640 shares — an estimated $199K sold.

UBS AM first reported a position in QTTB in Q4 2019 and held it in 10 quarters. The position peaked at $588K in Q2 2021. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • UBS AM reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 3,640 Q32 Bio shares in Q2 2022, an estimated $199K.
  • UBS AM first reported a position in Q32 Bio in Q4 2019 and held it in 10 quarters.
  • UBS AM's Q32 Bio position peaked at $588K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.